TRES BIOTECHNOLOGY AS
Operating
Rådgivning og tjenester i bioteknologi. Holdingselskap for selskaper
innen livsvitenskaper.
Holdingselskap. Konsulenttjenester for legemiddelindustri og
bioteknologi.
Organization
- CEO
- BT
- Chairman of the board
- BT
- Years since formation
- 3 years
- since Nov 7, 2023
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 2
- persons
Financials
- Annual total result 2025
- -5,795
- NOK
- Total equity 2025
- 147,767
- NOK
Last update: Jun 2, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
BT | Managing Director/CEO | 50 % directly |
Board
| Name | Role | Shares |
|---|---|---|
BT | Chairman | 50 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
BT | Managing Director/CEO, Chairman | 50 % directly |
LT | - | 50 % directly |
Last update: Nov 7, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
BT | Ordinary shares | 500 | 50 % |
LT | Ordinary shares | 500 | 50 % |
Shares owned by the TRES BIOTECHNOLOGY AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 7,250 | 14.5 % | |
| Ordinary shares | 92 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 0 | 140,708 | 27,760 |
Annual Total Result | -5,795 | 106,253 | 22,879 |
Total assets | 172,885 | 183,562 | 52,190 |
Total liabilities | 25,118 | 30,000 | 4,881 |
Total equity | 147,767 | 153,562 | 47,309 |
P&L
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 0 | 140,708 | 27,760 |
Total operating costs | 5,795 | 4,340 | 0 |
Operating result | -5,795 | 136,368 | 27,760 |
Financial income/costs | 0 | 0 | 0 |
Profit before tax | -5,795 | 136,368 | 27,760 |
Total tax & extraordinary income/cost | 0 | 30,115 | 4,881 |
Annual Total Result | -5,795 | 106,253 | 22,879 |
Balance overview
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total fixed assets | 7,250 | 7,250 | 0 |
Total current assets | 165,635 | 176,312 | 52,190 |
Total assets | 172,885 | 183,562 | 52,190 |
Short term debt | 25,118 | 30,000 | 4,881 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 25,118 | 30,000 | 4,881 |
Contributed capital | 30,000 | 30,000 | 24,430 |
Retained earnings | 117,767 | 123,562 | 22,879 |
Total equity | 147,767 | 153,562 | 47,309 |
Total equity and liabilities | 172,885 | 183,562 | 52,190 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises